TNF Pharmaceuticals Statistics Share Statistics TNF Pharmaceuticals has 14.18M
shares outstanding. The number of shares has increased by 498.38%
in one year.
Shares Outstanding 14.18M Shares Change (YoY) 498.38% Shares Change (QoQ) 414.83% Owned by Institutions (%) n/a Shares Floating 134.78K Failed to Deliver (FTD) Shares 55,477 FTD / Avg. Volume 2.42%
Short Selling Information The latest short interest is 2.78M, so 19.59% of the outstanding
shares have been sold short.
Short Interest 2.78M Short % of Shares Out 19.59% Short % of Float 19.63% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.12 and the forward
PE ratio is null.
TNF Pharmaceuticals's PEG ratio is
0.
PE Ratio -0.12 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0.19 P/FCF Ratio -0.31 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for TNF Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.4,
with a Debt / Equity ratio of 0.
Current Ratio 1.4 Quick Ratio 1.4 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-11.68M Employee Count 2 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -2.78M Effective Tax Rate 11.92%
Stock Price Statistics The stock price has increased by -99.9% in the
last 52 weeks. The beta is 2.32, so TNF Pharmaceuticals's
price volatility has been higher than the market average.
Beta 2.32 52-Week Price Change -99.9% 50-Day Moving Average 10.6 200-Day Moving Average 50.57 Relative Strength Index (RSI) 30.71 Average Volume (20 Days) 2,294,193
Income Statement
Revenue n/a Gross Profit n/a Operating Income -10.17M Net Income -23.36M EBITDA -23.36M EBIT -8.66M Earnings Per Share (EPS) -11.08
Full Income Statement Balance Sheet The company has 173.15K in cash and 10.58K in
debt, giving a net cash position of 162.57K.
Cash & Cash Equivalents 173.15K Total Debt 10.58K Net Cash 162.57K Retained Earnings -129.14M Total Assets 21.42M Working Capital 2.71M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -8.98M
and capital expenditures 0, giving a free cash flow of -8.98M.
Operating Cash Flow -8.98M Capital Expenditures n/a Free Cash Flow -8.98M FCF Per Share -3.68
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields TNFA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for TNFA.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 2, 2025. It was a
backward
split with a ratio of 1:100.
Last Split Date Sep 2, 2025 Split Type backward Split Ratio 1:100
Scores Altman Z-Score -9.13 Piotroski F-Score 2
